All Type of News
Astellas become first Japanese pharmaceutical branch with KRW 200 billion annual sales
Astellas Pharma Korea(CEO Hae-do Jung) has enter the sales wall of KRW 200 billion for the first time as a Japanese multinational pharmaceutical company branched in the Korean market.
According to the electronic off...
MFDS’s high-intensity integrity measure impacts pharmaceutical industry
Even since the Ministry of Food and Drug Safety(MFDS) decided to enforce the high-intensity integrity measure, pharmaceutical companies have started to have concerns on operation related to the government.
While the ...
Erbitux’s enjoyment over RSA effect, Viread’s explosive upturn
‘Erbitux,’ the Merck’s targeted therapy for metastatic colorectal cancer, has well enjoyed the effect of the risk-sharing system.
Moreover, ‘Viread,’ the Gilead’s hepatitis B treatment, has shown an incredible growt...
The pharmacy is the ‘out of stock’ GSK is ‘supply’... Where is the many Dermovate?
Is it ‘out-of-stock’? It actually was told it has been supplied, though. Where all the drug could go?
The mystery of GSK’s Dermovate Soln 25ml & 50ml has reoccurred.
While the pharmaceutical company said it has supp...
‘Viead’ cruises both in prescription and importWhile ‘Viread(generic name: tenofovir), the Gilead’s hepatitis B therapy, outnumbered BMS’s ‘Baraclude’ and became the top in the ETC drug market, it continued a smooth flow as ...
|
GSK Vice President Tae-joon Yeon move to Home Plus
Vice President Tae-joon Yeon who led the Foreign Cooperation at GSK was decided to move to Home Plus.
Home Plus announced establishment of a foreign cooperation department for foreign cooperation, promotion and cris...
Multiple myeloma therapy, ‘Kyprolis’ conducted Phase 3 clinical trials on Koreans
The new multiple myeloma therapy, ‘Kyprolis(carfilzomib, Amgen),’ will start a Phase 3 clinical trial adding 16 Korean subjects.
It has attracted interests of the industry since it is a newly-approved clinical trial ...
Listed pharmaceuticals’ foreigner-owned stocks exceeded 20%
It was observed there were the total 6 public pharmaceutical companies having more than 20% of foreigner-owned stocks, such as Yuhan Corporation and Samjin Pharm.
According to the Yakup Shinmoon’s(www.yakup.com) anal...
Lower 20% insurance payers receive 5.1 time more benefits
It was observed the lower 20% health insurance payers bore monthly KRW 25,366 per family, and benefits they receive were KRW 128,431, 5.1 times than what they pay; moreover, the top 20% insurance payers receive 1.1 ti...
North Korea’s medical system lacks in basic infrastructure
What will be the North Korea’s current medical situation which has been isolated for 70 years?
At the AHKU’s(www.ahku.kr) Autumn Academic Symposium which was held at the Yoo Il-han Hall of Yonsei University’s Avison ...
